Publications by authors named "Junseon Min"

Claim this Profile
S
Synthetic biomolecular condensates enhance translation from a target mRNA in living cells.
Daniel Mark Shapiro, Sonal Deshpande, Seyed Ali Eghtesadi, Miranda Zhong, Cassio Mendes Fontes, Junseon Min

Nat Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentration-Independent Multivalent Targeting of Cancer Cells by Genetically Encoded Core-Crosslinked Elastin/Resilin-like Polypeptide Micelles.
Patrick Weber, Michael Dzuricky, Junseon Min, Irene Jenkins, Ashutosh Chilkoti

Biomacromolecules· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Study of the Interaction of Multivalent Ligand-Modified Nanoparticles with Breast Cancer Cells with Tunable Receptor Density.
Jing Wang, Junseon Min, Seyed Ali Eghtesadi, Ravi S Kane, Ashutosh Chilkoti

ACS Nano· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Recombinant Secondary Antibody Mimic as a Target-specific Signal Amplifier and an Antibody Immobilizer in Immunoassays.
Junseon Min, Eun Kyung Song, Hansol Kim, Kyoung Taek Kim, Tae Joo Park

Sci Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically engineering encapsulin protein cage nanoparticle as a SCC-7 cell targeting optical nanoprobe.
Hyojin Moon, Jisu Lee, Hansol Kim, Somin Heo, Junseon Min

Biomater Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An enhanced ascorbate peroxidase 2/antibody-binding domain fusion protein (APEX2-ABD) as a recombinant target-specific signal amplifier.
Jisu Lee, Eun Kyung Song, Yoonji Bae, Junseon Min, Hyun-Woo Rhee

Chem Commun (Camb)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform.
Hyojin Moon, Jisu Lee, Junseon Min, Sebyung Kang

Biomacromolecules· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of P22 viral capsid nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms.
Junseon Min, Hyojin Moon, Hyun Ji Yang, Hyun-Hee Shin, Sung You Hong

Macromol Biosci· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of P22 viral capsids as intravascular magnetic resonance T1 contrast conjugates via site-selective attachment of Gd(III)-chelating agents.
Junseon Min, Hoesu Jung, Hyun-Hee Shin, Gyunggoo Cho, HyungJoon Cho

Biomacromolecules· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis